Supply of 3rd Generation Recombinant Factor VIII and Other Medical Items for Indian Army
Indian Army · Pharmaceuticals · open
Key facts
- Tender value: ₹49.9L
- Closing date: 02 Jul 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for procurement of 3rd Generation Recombinant Factor VIII 500IU Inj, Vincristine Sulphate 1mg Inj, Romiplostin 250 mcg Inj, Cytosine Arabinoside 500mg Inj, Luspartercept 75 mg Inj, Posaconazole oral suspensions, Azacitidine 200 mg Tabs, Lutropin Alpha powder, and various other medical supplies with a total quantity of 88798 units, for Indian Army under Ministry of Defence.
Eligibility & requirements
- Past performance: 60%
- Startup relaxation: No
- MSE relaxation: No
Commercial terms
- Bid type: Packet Bid
- Evaluation: wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (10)
- 3rd Generation Recombinant Factor VIII 500IU Inj — Qty: 1
- Vincristine Sulphate 1mg Inj — Qty: 1
- Romiplostin 250 mcg Inj — Qty: 1
- Cytosine Arabinoside 500mg Inj — Qty: 1
- Inj Luspartercept 75 mg — Qty: 1
- Posaconazole 40 mg/ml Oral susp Bottle of 105 ml — Qty: 1
- Inj Posaconazole 300 mg — Qty: 1
- Eltrombopag 25 Mg Tab — Qty: 1
- Posaconazole 100 mg Tab — Qty: 1
- Azacitidine 200 mg Tab — Qty: 1
1 tender document(s) available — sign up to download.